| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| LEAD ACETATE | TOX-Non-Repro-Sublethal - organ/system effects | % packed cell volume versus controls | decreased | 10 | Adult | 15 weeks | Toxicity Factor Datasets |
| LEAD ACETATE | TOX-Non-Repro-Sublethal - organ/system effects | hemoglobin concentration versus controls | decreased | 10 | Adult | 15 weeks | Toxicity Factor Datasets |
| LEAD ACETATE | TOX-Non-Repro-Sublethal - cellular/biochemical effects | protoporphyrin concentration versus controls | increased | 10 | Adult | 15 weeks | Toxicity Factor Datasets |
| LEAD ACETATE | TOX-Non-Repro-Sublethal - cellular/biochemical effects | ALAD enzyme activity versus controls | decreased | 10 | Adult | 15 weeks | Toxicity Factor Datasets |
| LEAD ACETATE | TOX-Non-Repro-Sublethal - cellular/biochemical effects | iron concentration in liver versus controls | increased | 10 (controls); 30 (treated) | Adult | 15 weeks | Toxicity Factor Datasets |
| LEAD ACETATE | TOX-EXP IND - accumulation | liver and kidney Pb concentrations versus controls | increased | 30 | Adult | 15 weeks | Toxicity Factor Datasets |
